Brief: Rallybio To Provide Update On Rlyb116 Program
25/11/2024 13:12
Nov 25 (Reuters) - Rallybio Corp RLYB.O :
* RALLYBIO TO PROVIDE UPDATE ON RLYB116 PROGRAM, AN
INNOVATIVE
SUBCUTANEOUSLY INJECTED C5 INHIBITOR
Source text: ID:nBw44Tj4wa
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx